Probest Pharma Private Limited

Probest Pharma Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24239DL2002PTC114413 Incorporated 28 February 2002 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2024
₹21.09 Lakh
▼ 7% YoY
Net profit · FY 2024
₹18,019
Net margin 0.9%
EBITDA · FY 2024
₹1.94 Lakh
EBITDA margin 9.2%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹7 Lakh
Secured borrowings
Company age
24 yrs
Est. 2002
Directors on board
3
As per MCA filings

About Probest Pharma Private Limited

Data last updated:

Probest Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 28 February 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2002PTC114413. Its GSTIN is 09AADCP1185D1ZK (Uttar Pradesh).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Surinder Khurana and Manpreet Singh Khurana.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1537/28 Ist Floor Naiwala Karol Bagh, New Delhi, Delhi, India – 110005.

As per the financials filed for FY 2024, the company reported a revenue of ₹21.09 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹18,019 (net margin 0.9%) and EBITDA of ₹1.94 Lakh (EBITDA margin 9.2%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.

As per MCA filings, the company has open charges of ₹7 Lakh on record.

Probest Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0019307). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239DL2002PTC114413
Registration Number 114413
Incorporation Date 28 February 2002
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-56-0019307

Recognitions & Rankings of Probest Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-UP-56-0019307

Contact details

Probest Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    1537/28 Ist Floor Naiwala Karol Bagh, New Delhi, Delhi, India – 110005
  • Industry
    Healthcare, Medical Equipment Retail & Distribution

To see the full contact details of Probest Pharma Private Limited, buy the company report.

Comprehensive company report
Probest Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Probest Pharma is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Probest Pharma Private Limited, buy the company report.

Financials of Probest Pharma Private Limited

FY 2025 filings available

Probest Pharma Private Limited reported revenue of ₹21.09 Lakh (down 7% YoY) for FY 2024.

Revenue · FY 2024
₹21.09 Lakh ▼ 7%
Net profit · FY 2024
₹18,019 margin 0.9%
EBITDA · FY 2024
₹1.94 Lakh margin 9.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 3%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 11%
5 years · compounded
▲ 2%

Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 7% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.94 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹18,019
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.2%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Probest Pharma Private Limited, buy the company report.

Board of directors of Probest Pharma Private Limited

Probest Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Auditor

Probest Pharma Private Limited is audited by S A R S & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
S A R S & ASSOCIATESFY 2020021573N

Shareholding

The shareholding of Probest Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Probest Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7 Lakh
Satisfied charges
None
Breakdown by lending institutions
Punjab & Sind Bank₹0.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Aug 200810118797Punjab & Sind Bank₹7 LakhOpen

To see the full charge records of Probest Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Probest Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Probest Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AADCP1185D1ZKUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Probest Pharma Private Limited, buy the company report.

Recent activity

Probest Pharma Private Limited has 7 board changes on record since 2002: 3 appointments and 4 cessations. The latest: Surinder Khurana ceased to be Additional Director on 29 Sep 2024.

AGM
Probest Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Probest Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Surinder Khurana ceased to be Additional Director.
Appointed
Surinder Khurana was appointed as Director.
Charges
A charge with Punjab & Sind Bank of Rs. 7.00 Lakh registered on 07 Aug 2008 with Charge ID 10118797 was modified on 25 Feb 2013.
Charges
A charge with Punjab & Sind Bank amounted to Rs. 7.00 Lakh with Charge ID 10118797 was registered on 07 Aug 2008.
Ceased
Ashutosh Arora ceased to be Director.
Ceased
Kamal Gupta ceased to be Director.
Appointed
Narendra Pal Singh was appointed as Director.
Ceased
Pradeep Aswal ceased to be Managing Director.
Appointed
Manpreet Singh Khurana was appointed as Director.
Incorporation
28 Feb 2002
Probest Pharma Private Limited was registered on 28 Feb 2002 with Roc Delhi Ii & aged 24 years 8 months as per MCA records.

Frequently asked questions

Probest Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 28 February 2002 (24+ years old) and is registered under CIN U24239DL2002PTC114413.

Probest Pharma has 3 current directors:

The latest financial statements of Probest Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Probest Pharma is 09AADCP1185D1ZK, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Probest Pharma is U24239DL2002PTC114413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Probest Pharma was incorporated on 28 February 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.

Surinder Khurana ceased to be Additional Director on 29 Sep 2024. Surinder Khurana was appointed as Director on 13 Sep 2024. Ashutosh Arora ceased to be Director on 22 Feb 2008. Probest Pharma has 7 board changes on record in total.

Yes, Probest Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-56-0019307).

The registered office of Probest Pharma is at 153728 Ist Floor Naiwala Karol Bagh, New Delhi, Delhi, India – 110005.

Probest Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.